Bioassay Gene Genetic Engineering Genetics 
Drug Discovery World
NOVEMBER 9, 2023
Advances in analytical techniques and approaches This session is made up of four presentations which include: Christian Graf, PhD, Fellow, Scientific Office, Novartis TRD Biologics, on: ‘MS-based cell bioassays: A novel tool for biotherapeutics characterisation’. The session ends with two presentations and two luncheon presentations.
Drug Discovery World
MAY 10, 2023
Carcinogenicity testing For decades, the two-year rodent bioassay has been the regulatory standard used to determine the carcinogenic potential of new drugs. This process historically involved lifetime carcinogenicity bioassays in two species. Figure 1: Comparing Carcinogenicity Testing Timelines in Transgenic vs. Standard Mice.
Expert insights. Personalized for you.
52 
Let's personalize your content